NLM Gateway
A service of the U.S. National Institutes of Health
Your Entrance to
Resources from the
National Library of Medicine
    Home      Term Finder      Limits/Settings      Search Details      History      My Locker        About      Help      FAQ    
Skip Navigation Side Barintended for web crawlers only

A global AIDS related biotechnology transfer protocol (GARBTTP) to facilitate access to AIDS prophylactics in developing countries.

Thomas J; International Conference on AIDS.

Int Conf AIDS. 1998; 12: 837 (abstract no. 42320).

AIDS Advocacy Alliance, Chai Wan, Hong Kong.

ISSUE: Further efforts in facilitating Access to AIDS treatment in developing countries. PROJECT: A plea to UNAIDS to initiate a process by which existing AIDS related bio-technological knowledge, facilities or capabilities are rapidly utilised to fulfil the needs in developing countries. This process involves, identifying all the currently available AIDS related bio-technical resources, identifying potential users in developing countries (e.g., government labs and bio-technology companies in developing countries), and a UNAIDS mediated bio technology transfer protocol to interface the two. Collaboration should also be sought from World Intellectual Property Organisation (WIPO) and World Trade Organisation (WTO). GUIDING PRINCIPLES: Acknowledging the global inter dependence, all AIDS related medical and biotechnological advances are to be considered as a global heritage. THE GOALS AND SERVICES: The primary goal of GARBTTP is to expedite the transfer of technology from the numerous laboratories throughout the world to the end-users. The services provided by GARBTTP will fall into four major categories: Business & Operations Management services to assist in identifying policies related to intellectual property rights, global trade agreements, management, production and general operations problems that hinder AIDS related bio technology transfer. Research, Planning & Development services focusing on all phases of technology development leading to new products and processes in various countries and by partner agencies. This includes identifying state-of-the-art technologies to be considered to be included in GARBTTP. Commercial services to assist clients in getting technology and/or products to the commercial marketplace at and developing mechanisms to make it affordable. This also might involve a global fund to compensate to acquire advance technology to be transferred Education & Training services designed to expand knowledge about treatment options, the types and status of technology available for transfer and the mechanisms for promoting this process. CONCLUSION: A UNAIDS sponsored global AIDS related biotechnology transfer initiative is essential to facilitate greater access to AIDS prophylactics in developing countries.

Publication Types:
  • Meeting Abstracts
Keywords:
  • Acquired Immunodeficiency Syndrome
  • Biotechnology
  • Condoms
  • Developing Countries
  • Health Services Needs and Demand
  • Human Rights
  • Humans
  • Intellectual Property
  • Organizations
  • Research
  • Technology
  • Technology Transfer
  • therapy
Other ID:
  • 98403249
UI: 102231118

From Meeting Abstracts




Contact Us
U.S. National Library of Medicine |  National Institutes of Health |  Health & Human Services
Privacy |  Copyright |  Accessibility |  Freedom of Information Act |  USA.gov